Endofotonics

 

 

Endofotonics is a digital health organisation dedicated to using its proprietary Raman spectroscopy platform technology to improve early cancer detection and hence reduce cancer burden in patients. Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDx™ system, the world’s first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.